HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
批准号:
2856253
负责人:
ALPHONSE E SIRICA
金额:
$25.9万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-02-16 至 2000-12-31
关键词:
3T3 cells adenocarcinoma bile ducts biliary tract neoplasm cell differentiation cell type cellular oncology disease /disorder model furans gap junctions gastrointestinal epithelium gene expression growth factor receptors hepatocyte growth factor laboratory rat liver cells membrane channels metaplasia model design /development neoplasm /cancer classification /staging neoplastic transformation pluripotent stem cells protooncogene simian virus 40 stem cells tissue /cell culture transfection
中文摘要
描述(改编自研究者摘要):证据是
先前从严重肝损伤的新型体内大鼠模型中获得
和呋喃诱导的肝内胆管癌的发生,
提示典型增生胆管上皮细胞可
改变它们沿着胆管细胞谱系分化的承诺
以便作为化生小细胞兼性祖细胞
膀胱样腺体或独特的导管状肝细胞样细胞。
此外,胆汁细胞来源的“肠-
型”腺癌优先发展在肝脏的呋喃
治疗的老鼠为了更明确地确定是否为典型增生性
胆管上皮细胞能够作为一种兼性
多能干细胞样细胞在胆管癌发生过程中的作用,
严重肝损伤的类型,以下具体目标将是
追求:(1)实现培养群体的肿瘤转化
大鼠增生的胆管上皮细胞明显
与增殖的大鼠肝卵圆细胞群不同,
首次建立差异化潜力的目的
当这些更典型的胆管细胞转化为它们的
通过选择体外转化处理的致瘤表型;(2)
基于初步发现,确定(a)共转染
c-met原癌基因编码肝细胞受体,
生长因子/分散因子(HGF/SF)和HGF/SF生长因子基因
培养的大鼠增生性胆管上皮细胞
(B)如果这些相应的细胞的过表达
基因可能与转化的细胞的优先分化相关,
沿着小肠谱系的胆管细胞;和(3)使用间隙
连接基因作为分子生物标志物,以进一步建立
增生性胆管上皮细胞之间的谱系关系
型和导管肝细胞,形成在大鼠肝脏中的反应
呋喃引起的严重肝损伤。预计该
拟议研究产生的结果可能有助于
一个重要的方式来促进我们目前对肝脏的理解,
干细胞假说,以及大大增加我们目前的
肝胆管的细胞起源和组织发生的知识
癌的
英文摘要
DESCRIPTION (adapted from the investigator's abstract): Evidence was
previously obtained from novel in vivo rat models of severe liver injury
and intrahepatic cholangiocarcinogenesis induced by furan to strongly
suggest that typical hyperplastic bile ductular epithelial cells can
alter their commitment to differentiate along the biliary cell lineage
so as to act as facultative cell progenitors of either metaplastic small
intestinal-like glands or of unique ductular hepatocytic-like cells.
Moreover, a very high incidence of biliary cell-derived "intestinal-
type" adenocarcinomas preferentially developed in the livers of the furan
treated rats. To more definitively establish if typical hyperplastic
bile ductular epithelial cells are capable of acting as a facultative
pluripotent stem-like cell during cholangiocarcinogenesis and in certain
types of severe hepatic injury, the following specific aims will be
pursued: (1) Achieve neoplastic transformation of cultured populations
of rat hyperplastic bile ductular epithelial cells that are clearly
distinct from proliferating rat liver oval cell populations for the
purpose of establishing for the first time the differentiation potential
of these more typical bile ductular cells when converted to their
tumorigenic phenotype by selected in vitro transforming treatments; (2)
Based on the preliminary findings, determine if (a) cotransfection of
both the c-met protooncogene, which encodes the receptor for hepatocyte
growth factor/scatter factor (HGF/SF), and the HGF/SF growth factor gene
into cultured populations of rat hyperplastic bile ductular epithelial
cells in tumorigenic, and (b) if the overexpression of these respective
genes may correlate with a preferential differentiation of transformed
biliary cells along the small intestinal lineage; and (3) Use gap
junction genes as molecular biomarkers to further establish the temporal
lineage relationship between hyperplastic bile ductular epithelial cell
types and ductular hepatocytes that form in the rat liver in response
to severe hepatic injury induced by furan. It is anticipated that the
results generated by the proposed research are likely to contribute in
a significant way to furthering our current understanding of the hepatic
stem cell hypothesis, as well as to add considerably to our present
knowledge of the cellular origins and histogenesis of hepatobiliary
cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine
-
批准号:10747566
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2023
-
负责人:ALPHONSE E SIRICA
-
依托单位:
FASEB Growth Factor Receptor Tyrosine Kinases Confence
-
批准号:6359929
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2001
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7172654
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILLIARY CANCER
-
批准号:6023971
-
项目类别:
-
资助金额:$27.77万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6865103
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6693829
-
项目类别:
-
资助金额:$26.19万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7339683
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILLIARY CANCER
-
批准号:6350400
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
Altered Growth Factor Pathways in Biliary Cancer
-
批准号:8499770
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7558284
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
Altered Growth Factor Pathways in Biliary Cancer
-
批准号:8829763
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
Altered Growth Factor Pathways in Biliary Cancer
-
批准号:9228939
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6628421
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:7009272
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
-
批准号:6497936
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2000
-
负责人:ALPHONSE E SIRICA
-
依托单位:
FASEB GROWTH FACTOR RECEPTOR TYROSINE KINASES CONFERENCE
-
批准号:2869480
-
项目类别:
-
资助金额:$0.9万
-
财政年份:1999
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:6137427
-
项目类别:
-
资助金额:$26.92万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:2089765
-
项目类别:
-
资助金额:$22.15万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:7812168
-
项目类别:
-
资助金额:$28.9万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO
-
批准号:7305108
-
项目类别:
-
资助金额:$27.95万
-
财政年份:1996
-
负责人:ALPHONSE E SIRICA
-
依托单位:
国内基金
海外基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
-
批准号:30840003
-
项目类别:专项基金项目
-
资助金额:12.0万元
-
批准年份:2008
-
负责人:焦宇飞
-
依托单位: